Baird lowered the firm’s price target on Patterson Companies to $28 from $30 and keeps a Neutral rating on the shares. The firm said the company’s Q1 miss has raised questions from investors about both dental and vet end markets. But after the company’s conference call, Baird believes most FQ1 issues were company-specific and don’t point to worsening end markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Notable companies reporting before tomorrow’s open
- PDCO Earnings this Week: How Will it Perform?
- Dentsply Sirona reports one-year notice of non-renewal delivered to Patterson
- Patterson Dental, Pearl partner to advance dental AI in Canada
- Ex-Dividend Date Nearing for These 10 Stocks – Week of July 15, 2024
Questions or Comments about the article? Write to editor@tipranks.com